Spectra for:
Ch. Bharathi, K. Joseph Prabahar, Ch. S. Prasad, M. Saravana Kumar, S. Magesh, V.K. Handa, Ramesh Dandala, A. Naidu
6-PROPENYLOXO_ZALEPLON;IMPURITY_VII;N-[3-(3-CYANO-6-[(E)-3-((N-ETHYL-N-ACETYL)-AMINO)-PHENYL-3-OXOPROP-1-ENYL]-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYL
![6-PROPENYLOXO_ZALEPLON;IMPURITY_VII;N-[3-(3-CYANO-6-[(E)-3-((N-ETHYL-N-ACETYL)-AMINO)-PHENYL-3-OXOPROP-1-ENYL]-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYL](/api/compound/BQsIO7KK4Jb.png?h=300&w=458 "6-PROPENYLOXO_ZALEPLON;IMPURITY_VII;N-[3-(3-CYANO-6-[(E)-3-((N-ETHYL-N-ACETYL)-AMINO)-PHENYL-3-OXOPROP-1-ENYL]-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYL")
N-(3-(3-(4-AMINO-2-H-PYRAZOLO-[3.4-D]-PYRIMIDIN-6-YL)-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL)-N-ETHYLACETAMIDE;IMPURITY_I
![N-(3-(3-(4-AMINO-2-H-PYRAZOLO-[3.4-D]-PYRIMIDIN-6-YL)-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL)-N-ETHYLACETAMIDE;IMPURITY_I](/api/compound/IvD82IvIvBh.png?h=300&w=458 "N-(3-(3-(4-AMINO-2-H-PYRAZOLO-[3.4-D]-PYRIMIDIN-6-YL)-PYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL)-N-ETHYLACETAMIDE;IMPURITY_I")
N-[3-(3-CARBOXAMIDOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_II;ZALEPLON-CARBOXAMIDE
![N-[3-(3-CARBOXAMIDOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_II;ZALEPLON-CARBOXAMIDE](/api/compound/90OH7zYwfzS.png?h=300&w=458 "N-[3-(3-CARBOXAMIDOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_II;ZALEPLON-CARBOXAMIDE")
N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-5-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_V
![N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-5-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_V](/api/compound/EaRgtzHQo4h.png?h=300&w=458 "N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-5-YL)-PHENYL]-N-ETHYLACETAMIDE;IMPURITY_V")
N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-ACETAMIDE;IMPURITY_III;DESETHYL_ZALEPLON
![N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-ACETAMIDE;IMPURITY_III;DESETHYL_ZALEPLON](/api/compound/9aKPfg7KY8.png?h=300&w=458 "N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-ACETAMIDE;IMPURITY_III;DESETHYL_ZALEPLON")
N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLAMINE;DESETHYL-ZALEPLON;IMPURITY_VI
![N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLAMINE;DESETHYL-ZALEPLON;IMPURITY_VI](/api/compound/K6watrQ8fJZ.png?h=300&w=458 "N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-ETHYLAMINE;DESETHYL-ZALEPLON;IMPURITY_VI")
N-METHYL-ZALEPLON;IMPURITY_IV;N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-METHYLACETAMIDE
![N-METHYL-ZALEPLON;IMPURITY_IV;N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-METHYLACETAMIDE](/api/compound/FpciriCkdRa.png?h=300&w=458 "N-METHYL-ZALEPLON;IMPURITY_IV;N-[3-(3-CYANOPYRAZOLO-[1.5-A]-PYRIMIDIN-7-YL)-PHENYL]-N-METHYLACETAMIDE")
Zaleplon
Citation
| Citation | J.PHARM.BIOM.ANAL.,44,101(2007) |
|---|---|
| Journal | Journal of Pharmaceutical and Biomedical Analysis |
| Issue | 1 |
| Volume | 44 |
| Page(s) | 101-109 |
| Year | 2007 |
| Author(s) | Ch. Bharathi, K. Joseph Prabahar, Ch. S. Prasad, M. Saravana Kumar, S. Magesh, V.K. Handa, Ramesh Dandala, A. Naidu |
| Publisher | Elsevier BV |
| DOI | 10.1016/j.jpba.2007.01.051 |